AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.

This white paper examines how Samsung Biologics and the industry at large apply a quality by design (QbD) approach to ...